Isosorbide Dinitrate And Hydralazine Hydrochloride Tablet, Film Coated
Product Images NDC 73141-012

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Isosorbide Dinitrate And Hydralazine Hydrochloride (NDC 73141-012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A2a Integrated Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

This is a Kaplan-Meier plot showing the time to death in Black patients from the A-HeFT study. The plot compares the impact of Isosorbide Dinitrate and Hydralazine Hydrochloride versus Placebo, indicating a significant 43% reduction in mortality. The x-axis represents time in days, and the y-axis shows the number of patients at risk.*

FDA Label Image

Figure2 (Figure2)

This text presents a Kaplan-Meier plot showing a 39% risk reduction in first hospitalization for heart failure in Black patients from the A-HeFT study. It compares the time to first hospitalization for heart failure between Isosorbide Dinitrate and Hydralazine Hydrochloride tablets group (N=518) and Placebo group (N=532). The plot also indicates that the risk reduction is statistically significant with a P-value of less than 0.001 based on the Log-Rank Test. Time is represented in days on the x-axis, showing the percentage of patients without hospitalization over time.*

FDA Label Image

Figure3 (Figure3)

FDA Label Image

Figure4 (Figure4)

FDA Label Image

Hcl (Hcl)

FDA Label Image

Isdn-180label (Isdn 180label)

This is a medication containing isosorbide dinitrate and hydralazine in the form of tablets. Each tablet has 20 mg of isosorbide dinitrate and 37.5 mg of hydralazine. The tablets should be stored at room temperature between 15°C - 30°C (59°F - 86°F). The usual dosage instructions can be found on the package insert. This medication is distributed by A2A Integrated Pharmaceuticals and is prescribed under Rx Only. Each pack contains 180 tablets.*

FDA Label Image

Isdn-90label (Isdn 90label)

This text provides information about a medication labeled as NDC 73141-012-03, containing 20 mg isosorbide dinitrate and 37.5 mg Hydralazine HCl per tablet. The storage recommendation is to store at room temperature. The typical dosage instructions can be found in the package insert. The medication is distributed by A2A Integrated Pharmaceuticals in Bowling Green, KY, with a total of 90 tablets in the package.*

FDA Label Image

Isdn (Isdn)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.